RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 161 filers reported holding RELAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435,462 | -24.1% | 51,779 | +13.4% | 0.00% | – |
| Q2 2023 | $573,490 | -77.9% | 45,660 | -71.0% | 0.00% | -100.0% |
| Q1 2023 | $2,591,439 | -26.8% | 157,343 | -33.6% | 0.00% | -50.0% |
| Q4 2022 | $3,540,242 | -59.4% | 236,964 | -39.3% | 0.00% | -60.0% |
| Q3 2022 | $8,726,000 | +227.4% | 390,108 | +145.2% | 0.01% | +400.0% |
| Q2 2022 | $2,665,000 | -8.9% | 159,115 | +62.7% | 0.00% | 0.0% |
| Q1 2022 | $2,926,000 | -4.9% | 97,779 | -2.4% | 0.00% | 0.0% |
| Q4 2021 | $3,077,000 | +128.1% | 100,218 | +134.1% | 0.00% | 0.0% |
| Q3 2021 | $1,349,000 | -5.2% | 42,801 | +10.1% | 0.00% | 0.0% |
| Q2 2021 | $1,423,000 | +29.6% | 38,889 | +22.5% | 0.00% | 0.0% |
| Q1 2021 | $1,098,000 | +5.2% | 31,745 | +26.3% | 0.00% | 0.0% |
| Q4 2020 | $1,044,000 | +42.4% | 25,137 | +46.0% | 0.00% | 0.0% |
| Q3 2020 | $733,000 | – | 17,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |